Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape.
Restifo
N P
NP
National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. restifo@nih.gov
D016923:Cell Death; D053222:Fas Ligand Protein; D007108:Immune Tolerance; D007111:Immunity, Cellular; D008562:Membrane Glycoproteins / Q000276:immunology*; D018448:Models, Immunological; D014181:Transplantation Immunology / Q000276:immunology*; D019139:Tumor Escape / Q000276:immunology*
D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins